DK172840B1 - Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c - Google Patents

Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c Download PDF

Info

Publication number
DK172840B1
DK172840B1 DK198703366A DK336687A DK172840B1 DK 172840 B1 DK172840 B1 DK 172840B1 DK 198703366 A DK198703366 A DK 198703366A DK 336687 A DK336687 A DK 336687A DK 172840 B1 DK172840 B1 DK 172840B1
Authority
DK
Denmark
Prior art keywords
monoclonal antibody
antibody
flagella
crl
type
Prior art date
Application number
DK198703366A
Other languages
Danish (da)
English (en)
Other versions
DK336687D0 (da
DK336687A (da
Inventor
Anthony W Siadak
Mark E Lostrom
Mae Joanne Rosok
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of DK336687D0 publication Critical patent/DK336687D0/da
Publication of DK336687A publication Critical patent/DK336687A/da
Application granted granted Critical
Publication of DK172840B1 publication Critical patent/DK172840B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198703366A 1986-07-03 1987-06-30 Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c DK172840B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US88198486 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US94655486 1986-12-24
US4814387A 1987-05-15 1987-05-15
US4814387 1987-05-15

Publications (3)

Publication Number Publication Date
DK336687D0 DK336687D0 (da) 1987-06-30
DK336687A DK336687A (da) 1988-01-04
DK172840B1 true DK172840B1 (da) 1999-08-09

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198703366A DK172840B1 (da) 1986-07-03 1987-06-30 Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c

Country Status (19)

Country Link
JP (1) JP2639422B2 (enExample)
KR (1) KR910002373B1 (enExample)
AT (1) AT399885B (enExample)
AU (1) AU615162B2 (enExample)
BE (1) BE1000743A3 (enExample)
CH (1) CH677796A5 (enExample)
DE (1) DE3722098C2 (enExample)
DK (1) DK172840B1 (enExample)
ES (1) ES2013321A6 (enExample)
FR (1) FR2601458B1 (enExample)
GB (1) GB2192185B (enExample)
IE (1) IE60888B1 (enExample)
IL (1) IL83047A (enExample)
IT (1) IT1221940B (enExample)
LU (1) LU86938A1 (enExample)
NL (1) NL194961C (enExample)
OA (1) OA08629A (enExample)
PT (1) PT85247B (enExample)
SE (1) SE506421C2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
JPH02299594A (ja) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd ヒトモノクローナル抗体およびその製法
WO1990013033A1 (en) * 1989-04-14 1990-11-01 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
ATE188036T1 (de) * 1990-01-18 2000-01-15 Cura Nominees Pty Ltd Glykoalkaloide
WO2010091189A1 (en) * 2009-02-04 2010-08-12 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
US8653242B2 (en) 2010-03-01 2014-02-18 Lostam Pharmaceuticals Ltd. Therapeutic antibodies against flagellated Pseudomonas aeruginosa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
AU5991786A (en) * 1985-06-06 1987-01-07 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella

Also Published As

Publication number Publication date
DE3722098C2 (de) 1998-06-04
IE60888B1 (en) 1994-08-24
IT8721163A0 (it) 1987-07-02
DE3722098A1 (de) 1988-03-03
SE506421C2 (sv) 1997-12-15
IE871769L (en) 1988-01-03
AU7495887A (en) 1988-01-07
PT85247B (pt) 1990-06-29
SE8702734D0 (sv) 1987-07-02
JPS63102697A (ja) 1988-05-07
KR910002373B1 (ko) 1991-04-20
KR880001815A (ko) 1988-04-27
IL83047A0 (en) 1987-12-31
GB8715347D0 (en) 1987-08-05
NL194961C (nl) 2003-09-02
GB2192185B (en) 1991-01-16
ES2013321A6 (es) 1990-05-01
GB2192185A (en) 1988-01-06
CH677796A5 (enExample) 1991-06-28
BE1000743A3 (fr) 1989-03-28
NL194961B (nl) 2003-05-01
FR2601458A1 (fr) 1988-01-15
AU615162B2 (en) 1991-09-26
DK336687D0 (da) 1987-06-30
LU86938A1 (fr) 1988-02-02
ATA168387A (de) 1994-12-15
FR2601458B1 (fr) 1992-08-21
JP2639422B2 (ja) 1997-08-13
IT1221940B (it) 1990-08-31
DK336687A (da) 1988-01-04
SE8702734L (sv) 1988-01-04
OA08629A (en) 1988-11-30
NL8701554A (nl) 1988-02-01
IL83047A (en) 1992-12-01
PT85247A (en) 1987-08-01
AT399885B (de) 1995-08-25

Similar Documents

Publication Publication Date Title
US5662905A (en) Monoclonal antibody compositions cross-reactive and cross-protective against P. aeruginosa serotypes
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
IE832295L (en) Human monoclonal antibodies against bacterial toxins
OA10213A (en) Oral treatment of helicobacter infection
JP2645343B2 (ja) 交差防御性ヒト単クローン性抗体またはその結合フラグメントを含む医薬組成物
NL194961C (nl) Compositie omvattende een component die in staat is tot reactie met Pseudomonas aeruginosa flagella, farmaceutisch preparaat, cellijn, monoklonaal antilichaam, werkwijze ter bepaling van Pseudomonas aeruginosa, alsmede pakket voor het detecteren daarvan.
KR910004868B1 (ko) 인체 단일 클론항체 및 그것을 활성성분으로 함유하는 감염증의 예방 및 치료용 약학적 제제
WO1986007382A1 (en) Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
JPH0361428B2 (enExample)
JPH0355106B2 (enExample)

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired